Fundraising FoxBiotech Startups
11,051 companies tagged Biotech, with their investors and founders.
Inceptor Bio is a clinical-stage biotechnology company developing cell therapies for cancer, focused on solid tumors. Its OUTLAST platform reprograms T cells during manufacturing to withstand the tumor microenvironment, and its lead candidate is IB-T101.
0 investors
0 investors
Indapta Therapeutics develops an off-the-shelf, allogeneic FcRγ-deficient natural killer (g-NK) cell therapy derived from healthy donors to treat cancer and autoimmune diseases. Its lead candidate IDP-023 is being tested in clinical trials for indications such as multiple myeloma, non-Hodgkin's lymphoma, and progressive multiple sclerosis.
0 investors
Indaptus Therapeutics is a development-stage biopharmaceutical company conducting preclinical and clinical research on product candidates; the company has no approved products and generates no revenue from product sales, and funds operations through equity and debt financing.
0 investors
Inflammasome Therapeutics develops treatments for degenerative diseases including Alzheimer's disease, multiple sclerosis, macular degeneration, and Parkinson's disease. Its approach targets inflammasome activation as a mechanism to treat these conditions.
0 investors
InflammX Therapeutics develops Xiflam, a once-daily oral small molecule that inhibits the pathologically open Connexin43 hemichannel to modulate the NLRP3 inflammasome, targeting inflammation in retinal disease. Its lead indication is the dry form of age-related macular degeneration (dry AMD), for which there is currently no approved pharmacologic treatment.
0 investors
0 investors
0 investors
0 investors
0 investors
InGeneron develops regenerative cell therapies that use a patient's adult stem cells and other regenerative cells harvested from fat or bone marrow to treat specific injuries. The company focuses on developing FDA-approved therapies through clinical trials and research in the regenerative medicine field.
0 investors
0 investors
Inhibikase Therapeutics is a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics for pulmonary arterial hypertension (PAH). It is publicly traded on Nasdaq under the ticker IKT.
0 investors
0 investors
INmune Bio is a clinical-stage biotechnology company developing immunotherapies, including XPro1595, aimed at treating neurodegenerative and psychiatric diseases through a biomarker-directed approach. The company works on translating inflammatory therapies into clinical treatments for neurologic and other diseases.
0 investors
0 investors
0 investors
0 investors
InnovaPrep develops sample concentration instruments and air samplers used in environmental monitoring, food and product quality testing, life science research, and biopharmaceutical development. It also offers custom manufacturing and OEM services for matrix workflow applications.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors